JC
JPMorgan Chase & Co disclosed a 5.5% stake in LXEO
JPMorgan Chase & Co reported owning 5.5% of Lexeo Therapeutics, Inc. (LXEO) (4,573,701 shares) in a Schedule 13G filed Oct 13, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 13, 2026
- Source
- Schedule 13G